Table 2 Clinical data of the 143 patients with breast cancer
Variable | N (%) |
|---|---|
Menopausal status | |
Premenopausal | 45 (31.5) |
Postmenopausal | 98 (68.5) |
Bilateral breast cancer | 7 (5) |
Clinical stage | |
Stage I and II | 101 (70.6) |
Stage III | 31 (21.7) |
Stage IV | 11 (7.7) |
Molecular subtype | |
ER/PR-positive, HER2-negative | 78 (54.5) |
HER2-positive | 32 (22.4) |
Triple negative | 33 (23.1) |
Histology types | |
Invasive ductal carcinoma | 130 (90.9) |
Grade 1 | 15 (10.5) |
Grade 2 | 68 (47.5) |
Grade 3 | 39 (27.3) |
Unknown | 8 (5.6) |
Other cancer types | |
Invasive lobular carcinoma | 8 (5.6) |
Apocrine carcinoma | 1 (0.7) |
Mucinous carcinoma | 1 (0.7) |
Intracystic papillary carcinoma | 2 (1.4) |
Metaplastic carcinoma | 1 (0.7) |